Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C
- PMID: 35772010
- PMCID: PMC10336699
- DOI: 10.1080/00952990.2022.2082301
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C
Abstract
Background: Medications for opioid use disorder (MOUDs) are the gold standard for OUD treatment but are underused. To our knowledge, no published study has systematically identified and categorized state policy innovations for expanding MOUD utilization.Objective: We sought to identify and categorize state MOUD policy innovations.Methods: Within a stratified random sample of 16 U.S. states and Washington D.C. we searched for 2019 state statutes and regulations related to MOUD in Westlaw legal database. We then identified laws that appeared designed to increase MOUD utilization and categorized them using a template analysis approach.Results: We found 82 laws with one or more MOUD expansion policies. We identified six high-level MOUD expansion policy categories: 1) policies expanding the availability of waivered buprenorphine providers; 2) needs assessments and policies increasing public MOUD awareness; 3) criminal justice system policies; 4) Substance use disorder (SUD) treatment and sober living facility policies; 5) insurance policies; and 6) hospital policies. SUD treatment and housing facility policies, as well as insurance policies, were most common.Conclusions: Multipronged approaches are being pursued by several states to increase MOUD access. Our results can inform policymakers of MOUD expansion approaches in other jurisdictions. Policy categories can serve as the basis for policy variables for future analyses of policy effects.
Keywords: buprenorphine; criminal justice; insurance; law; medications for opioid use disorder; methadone; opioid use disorder; policy; qualitative; state.
Conflict of interest statement
Figures
References
-
- Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose death counts.: National Center for Health Statistics; 2021. [Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation.
-
- National Academies of Science Engineering & Medicine. Medications for Opioid Use Disorder Save Lives Washington D.C.: The National Academies Press; 2019. - PubMed
-
- Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2021. Contract No.: HHS Publication No. PEP21-07-01-003, NSDUH Series H-56.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical